Possible side effects may include: Mild injection-site discomfort Nausea or lightheadedness Temporary fatigue Review your health history, current medications, and any questions before starting treatment
In high-risk patients with T2D and CVD, CVOTs consistently show that sc and orally administered GLP-1RAs do not increase MACE risk compared with placebo
2-
Essentially, without enough dopamine, your brain may struggle to keep things clear and organized, which can lead to the frustrating experience of brain fog
Healthcare providers typically start with standard doses of each medication and titrate based on tolerability and glycemic response
The goal of the study was to ascertain whether GI adverse events (GI AEs), such as nausea/vomiting, diarrhea, constipation, and dyspepsia (indigestion), during the dose escalation phase (baseline to week 12) and from baseline to the end of treatment, are responsible for the greater weight loss seen with semaglutide compared to other GLP-1RAs
